Program

 Preliminary program
 

Day 1 - Friday, 6 March 2020

 
 08:30 AMOpening of the Workshop 
  

Pozniak, Anton 2019 2
Opening Lecture
Anton Pozniak, MD, FRCP - Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College, UK

 
 Session 1:  Research in HIV and Women Over the Last Decade:  Successes and Challenges 
 08:55 AM

Sharon Walmsley, FRCPC, MD, MSc

Antiretroviral Therapy, Women in Clinical Trials 
Sharon Walmsley, MD - Toronto University, Canada

 
 09:10 AM

Lynne Mofenson, MD

Prevention of Mother-to-Child Transmission
Lynne Mofenson, MD - Elizabeth Glaser AIDS Foundation, USA

 
 09:25 AM

Van der Straten, Ariane 2019 120x160

Prevention Options for Women
Ariane van der Straten, PhD - RTI International / UCSF, USA

 
 09:40 AM

Currier, Judith 2020 120x160

Comorbidities of Importance to Women
Judith Currier, MD - UCLA, USA

 
 09:55 AM

Sherr, Lorraine 2020 120x160

Psychosocial issues for women living with HIV
Lorraine Sherr, BA, DipClinPsych, PhD - University College London, UK

 
 10:10 AM

Clayden, Polly 2020 120x160

Involvement of Women Living with HIV in Research
Polly Clayden - iBase, UK

 
    
 10:25 AMCoffee Break 
    
  Abstract-Driven Presentations 
 10:55 AM

Sex-specific analyses in oral abstracts from CROI 2019
William Short, MD, MPH - University of Pennsylvania, USA

 #1
 11:10 AM

Outcomes following prenatal exposure to Dolutegravir: the Dolomite - EPPICC Study
Claire Thorne, BA, MSc, PhD - University College London, UK 

#2
 11:25 AM

Vitamin D status in pregnant women living with HIV in Denmark and association with birth outcomes - A nationwide cohort study
Ellen Moseholm, MScH, PhD - Copenhagen University Hospital, Hvidovre, Denmark

#3
 11:40 AM

Impact of Dolutegravir based  ART among Indian women
Poongulali Selvamuthu, MD - CART CRS /Infectious Diseases Medical Center, India

 #4

 11:55 AMDiscussion 
 12:25 PMGroup Picture 
    
 12:40 PM

Meet-the-expert Lunch
Table 1:  Antiretroviral trials:  Annette Haberl, Sharon Walmsley
Table 2:  PrEP:  Catherine Hankins, Sally Hodder
Table 3:  Pregnancy and breastfeeding:  Lynn Mofenson, Deborah Money, Natella Rakhmanina
Table 4:  Aging women:  Giovanni Guaraldi, Margaret Johnson
Table 5:  Mental health:  Mona Loutfy, Lorraine Sherr

 
    
 Session 2:  Debate:  U=U does not apply to women
 
 01:40 PM 

A Pro-Con Debate Involving Experts and Community Representatives

 
  

Natella Rakhmanina, MD, PhD, FAAP, AAHIVS

Natella Rakhmanina, MD, PhD - The George Washington University, Children’s National Health System, USA

 
  

Lena Serghides, PhD

 Lena Serghides, PhD - University Health Network, Canada

 
  

Fungai Murau

Fungai Murau, MA - IDS, UK

 
  

Sutherland, Lisa 2020 120x160

Lisa Sutherland - Social Worker, Canada

 
 02:40 PM

Coffee Break

 
  Abstract-Driven Presentations 
 03:10 PM

Maternal and cord plasma bioactive eicosanoid profiles differ in pregnant women living with HIV compared to HIV - negative pregnant women
Lena Serghides, PhD - University Health Network, Canada

#5
 03:25 PM

Adolescent girls and young women: Should they be formally recognized as a key population for HIV?
Madlen Nash, MSc - AIDS-Free World, Canada

 #6
 03:40 PM

Women on anti-retroviral therapy (ART) are less likely to achieve HIV RNA  <50 copies/ml compared to men –  Real World Data from the National Swedish InfCareHIV 
Asa Mellgren, MD, PhD - Clinic Of Infectious Diseases, Sweden 

#7
 03:55 PM

Not recommended, but done: Breastfeeding with HIV in Germany 
Lila Haberl, MD - Hivcenter, University Hospital, Goethe University, Germany

#8
    
 04:10 PMDiscussion 
    
 Session 3: ART Research in Pregnant and Breastfeeding Women
 
 04:25 PM

Lockman, Shahin 2020 120x160

Better, earlier pregnancy and lactation data for new HIV drugs: how do we get there
Shahin Lockman, MD, MSc - Harvard T.H. Chan School of Public Health, USA 

 
 04:40 PMRound Table Discussion 
  

Penazzato, Martina 2018

Martina Penazzato, MD, DTMH, MSC, PhD - World Health Organization, Switzerland

 
  

Lockman, Shahin 2020 120x160

Shahin Lockman, MD, MSc - Harvard T.H. Chan School of Public Health, USA 

 
  

Philadelphia Literacy

Kathleen Squires, MD - Merck Research Labs, USA

 
    
 5:10 PMWelcome drinks, poster viewing session and guided poster tour 1 
  

Women Race, Age and Regional US & Non-US Subgroup Analysis of Dolutegravir (DTG) and Non-integrase inhibitor treatment (non-INSTI) regimens in naïve randomized clinical trials at Week 48
Romina Quercia

 #16
  

ATLAS and FLAIR: Efficacy, pharmacokinetics and reasons for satisfaction in women with Cabotegravir & Rilpivirine long-acting regimen at week 48 
Romina Quercia

#17
  

Dolutegravir-containing ART does not reduce etonogestrel implant concentrations
Rena Patel

#18
  

Cabotegravir: Assessment of reproductive and developmental toxicity in animal studies 1
M.K. Ziejewski 

 #19

  

Cabotegravir pharmacokinetic tail in pregnancy and neonatal outcomes 
Parul Patel

 #20
    
 

Day 2 - Saturday, 7 March 2020

 
 Session 4: 90:90:90: Which Women Are Being Left Behind?
 
 08:30 AM

Hodder, Sally 2018

North America 
Sally Hodder, MD - West Virginia University, USA

 
 08:45 AM

Mariana Mardarescu, MD, PhD

Eastern Europe
Mariana Mardarescu, MD, PhD - Institute for Infectious Disease M. Bals, Romania

 
 09:00 AM

Africa
Tendani Gaolathe, MD - Botswana Harvard AIDS Institute Partnership, Botswana

 
 09:15 AM

Patricia Vasquez, MD

South America
Patricia Vasquez, MD - Hospital San Juan de Dios, Chile

 
 09:30 AM

India/Asia
Vidya Mave, MD - Bj Government Medical College, India

 
 09:45 AMDiscussion 
    
 10:15 AMCoffee Break, poster viewing session
 
  Guided poster tour 2: Pregnancy 
  

Achieving the third 95: Keeping adolescents living with HIV virally suppressed in rural Nigeria in test and treat era using Continuous Quality Improvement Model of Peer Counseling & Support Group
Saheed Usman

#21 
  

Timing of HIV diagnosis in HIV-positive pregnant women giving birth in a high prevalence Russian region
Rebecca Sconza

#22
  Mode of birth among women living with HIV: A population-based retrospective cohort study
Esther Shoemaker
#23
  Prevalence of polypharmacy and medication use contraindicated during pregnancy among a cohort of women living with HIV who are of childbearing age, 2016-2017
William Short
#24
  Clinical trial simulation to improve HIV pre-exposure prophylaxis dosing in pregnancy
Rachel Scott
#25 
    
  Guided poster tour 2: HIV transmission and progression  
  

Social media influence on the sexual behaviours of undergraduate students of the university of Buea, Cameroon
Ikome Theckla Efeti

#26
  

Why does sex make a difference in HIV clinical course? A bioinformatics analysis of differential expressed gene in male and female with HIV disease
Kulachanya Suwanwongse

#27
  HIV transmission patterns among people who inject drugs in the United States
Samira Sami
#28
  Disparities in PrEP uptake and adherence: implementation of routine adherence monitoring in Philadelphia PrEP clinic
Elijah Kahn-Woods
#29
  HIV/AIDS Prevention Interventions for Black Women in the U.S.:
A Systematic Review
Amber Sophus
#30
    
    
 Session 5:  Abstract-Driven Presentations
 
 11:15 AM 

Determinants of PrEP initiation in women at high risk for HIV
Rachel Scott, MD, MPH - Medstar Washington Hospital Center, USA

 #9
 11:30 AM

Validating incident pregnancies among women using contraceptives and antiretrovirals
Rena Patel, MD - University of Washington, USA

 #10
 11:45 AM

Post-Exposure Prophylaxis in Victims of Sexual Violence: Experience at the Condesa Specialized Clinic (CSC)
Teresita Cabrera, MD - Clínica Especializada Condesa, Mexico 

#11
 12:00 PM

Examining differences in syndemic factors by gender and sexual orientation among women, straight men, and gay, bisexual, and other men who have sex with men 
Kalysha Closson, MSc - University of British Columbia, Canada

#12
    
 12:15 PMDiscussion 
    
 12:30 PMLunch 
    
 Session 6: Women Surviving and Aging with HIV
 
 01:30 PM

Gustafson, Deborah 2019 120x160

WIHS Cohort
Deborah Gustafson, MS, PhD - SUNY Downstate Health Sciences University, USA

 
 02:00 PM

Giovanni Guaraldi 2017 120x160

Modena Cohort
Giovanni Guaraldi, MD - University of Modena and Reggio Emilia, Italy

 
 02:30 PMAveritt, Dawn 2020 120x160
Community Perspective
Dawn Averitt - The Well Project/WRI, USA
 
  Abstract-Driven Presentations 
 02:45 PM 

CD4:CD8 ratio normalization among treatment naive women
Alice Zhabokritsky, MD - University Of Toronto, Canada

 #13
 03:00 PM

Differences by gender and sexual orientation in treatment satisfaction and aspirations among persons living with HIV
Chinyere Okoli, PharmD - ViiV Healthcare, UK  

 #14
  

Attitudes towards health, sexual intimacy, and child-bearing among women living with HIV in 24 countries
Chinyere Okoli, PharmD - ViiV Healthcare, UK 

 
  

Gender, equality, and empowered decision-making in HIV care
Chinyere Okoli, PharmD - ViiV Healthcare, UK 

 
 03:15 PM

Impact of Microbial Exposures on HPV Immune Titers and Infection Among HPV-Vaccinated Women Living with HIV
Elisabeth McClymont, MD - University of British Columbia, Canada

#15

 03:30 PMDiscussion 
    
 03:45 PMClosing of the Workshop